Clinical trial
A Phase 2 Multicenter, Randomized, Double-blind, Parallel-group, Active-control, Dose-ranging Study to Evaluate the Safety, Efficacy, and Comparative Systemic Bioavailability of a Single Administration of SKY0402 Via Local Infiltration for Prolonged Postoperative Analgesia in Subjects Undergoing Total Knee Arthroplasty.
NCT00485693 is registered in ClinicalTrials.gov with Pacira Pharmaceuticals, Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2 Multicenter, Randomized, Double-blind, Parallel-group, Active-control, Dose-ranging Study to Evaluate the Safety, Efficacy, and Comparative Systemic Bioavailability of a Single Administration of SKY0402 Via Local Infiltration for Prolonged Postoperative Analgesia in Subjects Undergoing Total Knee Arthroplasty.
- Lead sponsor
- Pacira Pharmaceuticals, Inc
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 30, 2007
- Completion date
- August 31, 2009
- Enrollment
- 138 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.